Growing Incidence Of Autoimmune Diseases Fuels Demand For Humira Drug: The Driving Engine Behind Humira Drug Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Humira Drug Market Size Growth Forecast: What to Expect by 2025?
The market size for the Humira drug has been experiencing robust growth in the past few years. It is projected to expand from $9.74 billion in 2024 to $10.43 billion in 2025, at a compound annual growth rate (CAGR) of 7.0%. The exponential growth during the historic era can be credited to the launch of biologics, progress in biotechnology, patient requests for potent therapies, and changes in the physician's prescription habits.

How Will the Humira Drug Market Size Evolve and Grow by 2029?
Expectations are high for a robust expansion in the humira drug market size over the coming years. The market is projected to escalate to a solid $14.19 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.0%. Several factors are contributing to this predicted growth during the forecast period. These include the entrance of biosimilar market, amendments in healthcare policies, emphasis on cost-effectiveness, extensive investments in research and development, precision medicine, and personalized treatments. The forecast period is also viewing significant trends such as real-world evidence generation, broader utilization in pediatric groups, a shift in favour of self-administered drugs, the adoption of value-based pricing models, and the evolution of targeted therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/humira-drug-global-market-report

What Drivers Are Propelling the Growth of Humira Drug Market Forward?
The escalation in the prevalence of autoimmune disease is projected to boost the advancement of the humira drug market. Autoimmune disease, wherein the body's immune system assaults and obliterates healthy tissues and cells, contributes to the demand for the Humira drug, which is used for alleviating pain and inflammation instigated by various autoimmune conditions. Notably, in March 2024, the National Health Council, a US-based non-profit entity, unveiled that approximately 50 million Americans were affected by autoimmune diseases. Nonetheless, due to the diagnostic complexities of these conditions, this number is probably an understatement. Alarmingly, autoimmunity is nearing epidemic proportions with some research indicating an annual surge of 3-12%. Hence, the increase in the prevalence rate of autoimmune disease is anticipated to fuel the humira drug market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11934&type=smp

Which Emerging Trends Are Transforming the Humira Drug Market in 2025?
One of the primary trends in the humira drug market is product innovations. To maintain their dominance in the market, major firms in this sector are creating new biologics and biosimilar drugs. In a case in point, Sandoz, a pharmaceutical organization located in Switzerland, launched the Biosimilar Hyrimoz (adalimumab), a citrate-free high-concentration formulation (HCF) that received approval from the European Commission in April 2023. The introduction of this adalimumab citrate-free HCF (100mg/mL) formulation results in a 50% decrease in injection volume, thus reducing the number of injections required for patients who need 80 mg/mL or higher dosing. This development benefits a range of illnesses, including rheumatic diseases and Crohn's disease, to name a few, by providing an improved patient experience.

What Are the Key Segments in the Humira Drug Market?
The humira drug market covered in this report is segmented -

1) By Type: Humira Syringe, Humira Pen
2) By Application: Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn's Disease, Other Applications
3) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Humira Syringe: Pre-Filled Syringe, Disposable Syringe
2) By Humira Pen: Auto-Injector Pen, Pre-Filled Injection Pen

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11934&type=smp

Who Are the Key Players Shaping the Humira Drug Market's Competitive Landscape?
Major companies operating in the humira drug market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC, Celltrion Healthcare Co. Ltd., Cadila Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Mochida Pharmaceutical Co. Ltd., Innovent Biologics Inc., Biocad Biopharmaceutical Company, Shanghai Henlius Biotech Inc., Glenmark Pharmaceuticals Ltd., Samsung Bioepis Co Ltd., Hetero Healthcare Ltd., Coherus BioSciences Inc., CinnaGen Co., Alvotech Holdings S.A, Reliance Life Sciences Private Limited, Momenta Pharmaceuticals Inc., Bio-Thera Solutions Ltd., Fujifilm Kyowa Kirin Biologics Co. Ltd., BioXpress Therapeutics SA, Alteogen Inc., Prestige BioPharma Pte. Ltd.

What Geographic Markets Are Powering Growth in the Humira Drug Market?
North America was the largest region in the humira drug market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the humira drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11934

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.